What is the equity of Tasly Pharmaceutical Group Co this year?
Tasly Pharmaceutical Group Co has equity of 12.37 B CNY this year.
Tasly Pharmaceutical Group Co Equity 2024
Tasly Pharmaceutical Group Co Equity
12.37 B CNY
Ticker
600535.SS
ISIN
CNE000001C81
In 2024, Tasly Pharmaceutical Group Co's equity was 12.37 B CNY, a -0.46% increase from the 12.43 B CNY equity in the previous year.
Tasly Pharmaceutical Group Co Aktienanalyse
What does Tasly Pharmaceutical Group Co do?
Tasly Pharmaceutical Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Tasly Pharmaceutical Group Co's Equity
Tasly Pharmaceutical Group Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Tasly Pharmaceutical Group Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Tasly Pharmaceutical Group Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Tasly Pharmaceutical Group Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Tasly Pharmaceutical Group Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Tasly Pharmaceutical Group Co stock
What was the equity of Tasly Pharmaceutical Group Co compared to the previous year?
The equity of Tasly Pharmaceutical Group Co has increased/decreased by -0.46% decreased compared to the previous year.
What impact does a high equity have on investors of Tasly Pharmaceutical Group Co?
A high equity is advantageous for investors of Tasly Pharmaceutical Group Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Tasly Pharmaceutical Group Co?
A low equity can be a risk for investors of Tasly Pharmaceutical Group Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Tasly Pharmaceutical Group Co affect the company?
An increase in equity of Tasly Pharmaceutical Group Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Tasly Pharmaceutical Group Co affect the company?
A reduction in equity of Tasly Pharmaceutical Group Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Tasly Pharmaceutical Group Co?
Some factors that can affect the equity of Tasly Pharmaceutical Group Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Tasly Pharmaceutical Group Co so important for investors?
The equity of Tasly Pharmaceutical Group Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Tasly Pharmaceutical Group Co take to change the equity?
To change equity, Tasly Pharmaceutical Group Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Tasly Pharmaceutical Group Co pay?
Over the past 12 months, Tasly Pharmaceutical Group Co paid a dividend of 0.33 CNY . This corresponds to a dividend yield of about 2.04 %. For the coming 12 months, Tasly Pharmaceutical Group Co is expected to pay a dividend of 0.33 CNY.
What is the dividend yield of Tasly Pharmaceutical Group Co?
The current dividend yield of Tasly Pharmaceutical Group Co is 2.04 %.
When does Tasly Pharmaceutical Group Co pay dividends?
Tasly Pharmaceutical Group Co pays a quarterly dividend. This is distributed in the months of July, July, June, June.
How secure is the dividend of Tasly Pharmaceutical Group Co?
Tasly Pharmaceutical Group Co paid dividends every year for the past 23 years.
What is the dividend of Tasly Pharmaceutical Group Co?
For the upcoming 12 months, dividends amounting to 0.33 CNY are expected. This corresponds to a dividend yield of 2.01 %.
In which sector is Tasly Pharmaceutical Group Co located?
Tasly Pharmaceutical Group Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Tasly Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Tasly Pharmaceutical Group Co from 5/29/2024 amounting to 0.33 CNY, you needed to have the stock in your portfolio before the ex-date on 5/29/2024.
When did Tasly Pharmaceutical Group Co pay the last dividend?
The last dividend was paid out on 5/29/2024.
What was the dividend of Tasly Pharmaceutical Group Co in the year 2023?
In the year 2023, Tasly Pharmaceutical Group Co distributed 0.33 CNY as dividends.
In which currency does Tasly Pharmaceutical Group Co pay out the dividend?
The dividends of Tasly Pharmaceutical Group Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Tasly Pharmaceutical Group Co
Our stock analysis for Tasly Pharmaceutical Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tasly Pharmaceutical Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Tasly Pharmaceutical Group Co Revenue
- Tasly Pharmaceutical Group Co Net Income
- Tasly Pharmaceutical Group Co P/E
- Tasly Pharmaceutical Group Co P/S
- Tasly Pharmaceutical Group Co EBIT
- Tasly Pharmaceutical Group Co Dividend
- Tasly Pharmaceutical Group Co Stocks
- Tasly Pharmaceutical Group Co Market capitalization
- Tasly Pharmaceutical Group Co Debt
- Tasly Pharmaceutical Group Co Liabilities
- Tasly Pharmaceutical Group Co Equity
- Tasly Pharmaceutical Group Co AAQS
- Tasly Pharmaceutical Group Co Employees
- Tasly Pharmaceutical Group Co ROE
- Tasly Pharmaceutical Group Co ROA
- Tasly Pharmaceutical Group Co ROCE